Back to stocks
AVIR

AVIR

Atea Pharmaceuticals, Inc.• Healthcare

Q3 2026 filings are still coming in. 13F filers have 45 days after the quarter ends to report, through November 14, 2026. These totals cover only the funds that have filed so far and will keep rising.
Institutional holders
20
Partial Q3 2026
Total 13F value
$3.1M
Filed positions so far
New positions
2
This quarter
Sold positions
1
This quarter

Top holders

Institutions with disclosed positions in this stock

FundValueShares% PortfolioChange

Banque Pictet & Cie Sa

$1.8M345.1K0.01%Unchanged

Auour Investments Llc

$896K172.0K0.25%-2.8%

Bailard, Inc.

$84K16.1K0.00%Unchanged

China Universal Asset Management Co., Ltd.

$76K14.6K0.00%+14.9%

Sunpointe, Llc

$62K11.9K0.02%Unchanged

Wealth Enhancement Advisory Services, Llc

$58K11.3K0.00%New Position

Blue Trust, Inc.

$45K8.7K0.00%Unchanged

Fny Investment Advisers, Llc

$26K5.0K0.01%Unchanged

Versant Capital Management, Inc

$23K4.4K0.00%+4.2%

Gf Fund Management Co. Ltd.

$9K1.8K0.00%+8.8%

Sterling Capital Management Llc

$7K1.4K0.00%-2.2%

Sjs Investment Consulting Inc.

$3K5880.00%+129.7%

Farther Finance Advisors, Llc

$3K4940.00%+101.6%

Gamma Investing Llc

$3K4900.00%+438.5%

Essential Partners Llc

$2K3040.00%+3.4%

True Wealth Design, Llc

$6361220.00%Unchanged

Root Financial Partners, Llc

$6041160.00%New Position

Nisa Investment Advisors, Llc

$5521060.00%Unchanged

Ifp Advisors, Inc

$380730.00%Unchanged

Sbi Securities Co., Ltd.

$1020.00%Unchanged

Explore